Sensus scores Premier contract for brachytherapy
Superficial radiation therapy provider Sensus Healthcare has signed a group...Read more on AuntMinnie.comRelated Reading: Sensus inks R&D pact with UPenn Sensus touts research for nonmelanoma skin cancer FDA clears Sensus Healthcare's IORT system Sensus names new VP of clinical development Sensus appoints new sales VP for oncology (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 8, 2019 Category: Radiology Source Type: news

Sensus Healthcare Awarded Brachytherapy Products Agreement with Premier
BOCA RATON, Fla., May 8, 2019 -- (Healthcare Sales & Marketing Network) -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in novel radiation oncology technologies and solutions, has been awarded a group purchasing agreement ... Devices, Oncology, Dermatology, Group Purchasing Sensus Healthcare, superficial radiation therapy, skin cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 8, 2019 Category: Pharmaceuticals Source Type: news

Radiotherapy helped interior designer Emily, 33, beat cancer but she wouldn't get it under new rules
Emily Locking, of Buckinghamshire, was diagnosed with bowel cancer in 2015. After having selective internal radiation therapy, Emily was able to have surgery to help remove the cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - May 7, 2019 Category: Consumer Health News Source Type: news

Single-dose brachytherapy treats low-risk prostate cancer
A single session of high-dose-rate brachytherapy safely treated prostate cancer...Read more on AuntMinnie.comRelated Reading: Shorter radiotherapy works for prostate cancer treatment ASTRO: AI's rad therapy future is in predicting outcomes ASTRO: SBRT works well for less risky prostate cancer ASTRO releases new prostate radiation therapy guideline SNMMI: Early prostate cancer therapy extends lives (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 30, 2019 Category: Radiology Source Type: news

South Africa Hospital Delivers HDR Brachytherapy Cancer Treatments with Varian Bravos Afterloader System
PALO ALTO, Calif. and CAPE TOWN, South Africa, April 30, 2019 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) announced Groote Schuur Hospital in Cape Town, South Africa is the first hospital in Africa to deliver High Dose Rate (HDR) brach... Devices, Oncology Varian Medical Systems, Bravos afterloader, HDR brachytherapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 30, 2019 Category: Pharmaceuticals Source Type: news

Single - Dose Brachytherapy Effective for Prostate Cancer
Two - year and three - year biochemical progression - free survival rate of 100 percent for low - risk disease (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 30, 2019 Category: Cancer & Oncology Tags: Oncology, Radiology, Urology, Conference News, Source Type: news

Single-Dose Brachytherapy Effective for Prostate Cancer
MONDAY, April 29, 2019 -- Single-dose high dose-rate (HDR) brachytherapy is safe and effective for low-risk prostate cancer, according to a study presented at ESTRO 38, the annual meeting of the European Society for Radiotherapy and Oncology, held... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 29, 2019 Category: Pharmaceuticals Source Type: news

Single shot of radiation can save prostate cancer patients misery of weeks of treatment, study finds
High dose-rate brachytherapy – which delivers a surge of radiotherapy direct to the prostate in a single session – is safe and effective for men with low-risk cancer, researchers found. (Source: the Mail online | Health)
Source: the Mail online | Health - April 29, 2019 Category: Consumer Health News Source Type: news

3D Ultrasound gives clinicians clearer picture to treat gynaecological cancer
(University of Western Ontario) By transforming a conventional ultrasound probe, already found in most clinics, the technology can provide a 360-degree, three-dimensional view of surgical tools and surrounding tissue and organs. It provides a clearer and more accurate picture in the operating room for clinicians who need to precisely insert needles into the tumour for a procedure called interstitial brachytherapy, a type of targeted radiation therapy that uses intense energy to kill cancer cells in the tumour from the inside out. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 9, 2019 Category: International Medicine & Public Health Source Type: news

3D ultrasound gives clinicians clearer picture to treat gynecological cancer
(University of Western Ontario) By transforming a conventional ultrasound probe, already found in most clinics, the technology can provide a 360-degree, three-dimensional view of surgical tools and surrounding tissue and organs. It provides a clearer and more accurate picture in the operating room for clinicians who need to precisely insert needles into the tumor for a procedure called interstitial brachytherapy, a type of targeted radiation therapy that uses intense energy to kill cancer cells in the tumor from the inside out. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 9, 2019 Category: Cancer & Oncology Source Type: news

AngioDynamics wins expanded FDA clearance for OARtrac radiation dose monitor
AngioDynamics (NSDQ:ANGO) said late yesterday that it won expanded FDA 510(k) clearance for its OARtrac radiation dose monitoring system. With the new clearance, the Latham, N.Y.-based company’s OARtrac system is cleared for use with patient-specific, pre-calibrated Plastic Scintillating Detector sensors used during cancer treatments to monitor photon and electron radiation therapy as an adjunct to treatment planning. AngioDynamics’ OARtrac system is designed to enable the measurement and validation of targeted radiation doses to improve accuracy and allow for more informed dosing. “This expanded cle...
Source: Mass Device - March 29, 2019 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Radiosurgery/Radiation therapy Regulatory/Compliance AngioDynamics Source Type: news

Brachytherapy Boost Ups Survival in Locally Advanced Cervical Cancer
Findings observed regardless of treatment duration; disparities for brachytherapy use seen in vulnerable populations (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 25, 2019 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Radiology, Conference News, Source Type: news

Brachytherapy Boost Ups Survival in Locally Advanced Cervical Cancer
MONDAY, March 25, 2019 -- The current standard of care (SOC) for advanced cervical cancer -- external beam radiation therapy (EBRT) and chemotherapy in combination with brachytherapy -- provides significantly higher overall survival over... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 25, 2019 Category: Pharmaceuticals Source Type: news

Canadian community pitches in to buy an MRI
How much would you pay to bring a new MRI scanner to your hospital? Local hospital...Read more on AuntMinnie.comRelated Reading: Ontario ban on cremation after brachytherapy draws scrutiny Row erupts in Canada over radiologists' role in healthcare Canadian group tackles MRI waits through scheduling How IT innovation can improve healthcare in Canada Ottawa Hospital slashes lung cancer treatment time (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 21, 2019 Category: Radiology Source Type: news

Standard Brachytherapy Underused in Cervical Cancer
(MedPage Today) -- Black race, higher-stage disease tied to lower likelihood of receiving boost (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 17, 2019 Category: Hematology Source Type: news

Can radiation therapy and cremation safely coexist?
An increasing number of cancer patients are undergoing advanced radiation therapy...Read more on AuntMinnie.comRelated Reading: Ontario ban on cremation after brachytherapy draws scrutiny ACR, AAPM address radiation incident in Ariz. crematory Radiotracer contaminates crematorium after patient dies Brachytherapy error halts treatment at Canadian center SNMMI: New therapy aids patients with neuroendocrine tumors (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 14, 2019 Category: Radiology Source Type: news

Ontario ban on cremation after brachytherapy draws scrutiny
The Canadian province of Ontario is examining rules that ban the cremation...Read more on AuntMinnie.comRelated Reading: ACR, AAPM address radiation incident in Ariz. crematory Radiotracer contaminates crematorium after patient dies Brachytherapy error halts treatment at Canadian center (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 12, 2019 Category: Radiology Source Type: news

ACR, AAPM address radiation incident in Ariz. crematory
The American College of Radiology (ACR) and the American Association of Physicists...Read more on AuntMinnie.comRelated Reading: Radiotracer contaminates crematorium after patient dies Brachytherapy error halts treatment at Canadian center (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 5, 2019 Category: Radiology Source Type: news

iCAD partners with Swedish team on AI for breast cancer
Computer-aided detection (CAD) developer iCAD will collaborate with researchers...Read more on AuntMinnie.comRelated Reading: iCAD to highlight AI for tomosynthesis at ECR iCAD touts clinical results with Xoft Axxent brachytherapy iCAD highlights study results of DBT software FDA OKs iCAD's breast density AI software iCAD touts study on radiation therapy savings (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 28, 2019 Category: Radiology Source Type: news

Radiotracer contaminates crematorium after patient dies
Radiation from a radiopharmaceutical used to treat a patient who later died...Read more on AuntMinnie.comRelated Reading: Brachytherapy error halts treatment at Canadian center (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 26, 2019 Category: Radiology Source Type: news

iCAD to highlight AI for tomosynthesis at ECR
iCAD plans to highlight its artificial intelligence (AI) software for digital...Read more on AuntMinnie.comRelated Reading: iCAD touts clinical results with Xoft Axxent brachytherapy iCAD highlights study results of DBT software iCAD touts study on radiation therapy savings iCAD scores Chinese OK for balloon applicators iCAD to highlight Xoft clinical results at AAPM (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 26, 2019 Category: Radiology Source Type: news

ME & MY OPERATION: Why radiotherapy with a needle could beat cervical cancer
Karen Corrigan, 55, a mother-of-four from Colchester in Essex, tried a brand new treatment for cervical cancer called brachytherapy. This is her story. (Source: the Mail online | Health)
Source: the Mail online | Health - February 25, 2019 Category: Consumer Health News Source Type: news

Brachytherapy error halts treatment at Canadian center
A cancer center in Hamilton, Ontario, has suspended brachytherapy treatment...Read more on AuntMinnie.com (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 14, 2019 Category: Radiology Source Type: news

Varian CEO rings NYSE opening bell on World Cancer Day
Dow Wilson, president and CEO of radiation oncology firm Varian Medical Systems,...Read more on AuntMinnie.comRelated Reading: Varian posts Q1 revenue gains 1st Taiwanese patients treated with Varian HyperArc Varian gets Chinese trade tariff exemption Varian gets China OK for Halcyon system Varian launches Bravos brachytherapy system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 5, 2019 Category: Radiology Source Type: news

GT Medical lands $10m Series A for IsoRay ’ s GammaTile
GT Medical Technologies said today that it landed a $10 million Series A round for the GammaTile brachytherapy it co-developed with IsoRay (NYSE:ISR) to treat brain tumors. Richland, Wash.-based IsoRay and the Barrow Neurological Institute formed GT Medical to develop the technology to embed Cesium-131 brachytherapy seeds in collagen tiles to treat malignant meningioma, according to regulatory filings, inking a formal co-development deal in March 2017. By January of the following year the deal had expanded to include an exclusive, 10-year manufacturing & supply pact for GammaTile. In July 2018 ...
Source: Mass Device - January 31, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Featured Funding Roundup Radiosurgery/Radiation therapy Wall Street Beat GT Medical Technologies IsoRay Source Type: news

IsoRay's cesium-131 brachytherapy aids prostate surgery
Researchers from the Medical University of South Carolina have used medical...Read more on AuntMinnie.comRelated Reading: IsoRay's GammaTile therapy receives FDA OK IsoRay revenues climb in Q4 IsoRay highlights cesium-131 brachytherapy research IsoRay touts prostate cancer treatment data FDA responds to IsoRay's GammaTile 510(k) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 29, 2019 Category: Radiology Source Type: news

Varian posts Q1 revenue gains
Varian Medical Systems said it posted revenue gains in the first quarter of...Read more on AuntMinnie.comRelated Reading: 1st Taiwanese patients treated with Varian HyperArc Varian gets Chinese trade tariff exemption Varian gets China OK for Halcyon system Varian launches Bravos brachytherapy system Varian posts mixed results for fiscal 2018 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 25, 2019 Category: Radiology Source Type: news

Varian gets Chinese trade tariff exemption
The U.S. Trade Representative has approved a request from radiation oncology...Read more on AuntMinnie.comRelated Reading: Varian gets China OK for Halcyon system Varian launches Bravos brachytherapy system Varian posts mixed results for fiscal 2018 Varian launches single-room proton therapy at ASTRO Varian acquires oncology software company Noona (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 2, 2019 Category: Radiology Source Type: news

iCAD gets FDA nod for ProFound AI software for DBT
iCAD has received U.S. Food and Drug Administration (FDA) clearance for its...Read more on AuntMinnie.comRelated Reading: iCAD touts clinical results with Xoft Axxent brachytherapy iCAD highlights study results of DBT software FDA OKs iCAD's breast density AI software iCAD touts study on radiation therapy savings iCAD scores Chinese OK for balloon applicators (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 7, 2018 Category: Radiology Source Type: news

Varian gets China OK for Halcyon system
Radiation oncology firm Varian Medical Systems has received clearance for its...Read more on AuntMinnie.comRelated Reading: Varian launches Bravos brachytherapy system Varian posts mixed results for fiscal 2018 Varian launches single-room proton therapy at ASTRO Varian acquires oncology software company Noona Varian signs educational partner in India (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 28, 2018 Category: Radiology Source Type: news

Varian launches Bravos brachytherapy system
Radiation oncology firm Varian Medical Systems has introduced Bravos, a new...Read more on AuntMinnie.comRelated Reading: Varian posts mixed results for fiscal 2018 Varian launches single-room proton therapy at ASTRO Varian acquires oncology software company Noona Varian signs educational partner in India Varian makes changes at 2 divisions (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 26, 2018 Category: Radiology Source Type: news

iCAD touts clinical results with Xoft Axxent brachytherapy
iCAD is highlighting positive clinical results for its Xoft Axxent electronic...Read more on AuntMinnie.comRelated Reading: iCAD highlights study results of DBT software FDA OKs iCAD's breast density AI software iCAD touts study on radiation therapy savings iCAD scores Chinese OK for balloon applicators iCAD to highlight Xoft clinical results at AAPM (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 25, 2018 Category: Radiology Source Type: news

Varian Introduces Bravos Afterloader System with Customizable Pre-Treatment Checklist
The Bravos™ Afterloader System is designed for high dose rate brachytherapy treatments. The system comes with a touchscreen control that offers easy access to patient treatment information on the afterloader. The unit features instinctive LED lights (green, yellow and red) for guiding clinicians through the correct connection process of transfer guide tubes. It is offered with a customizable pre-treatment checklist helps clinician to set a review process such as time-out for patient...This story is related to the following:Medical Equipment& Supplies (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - October 23, 2018 Category: Medical Devices Source Type: news

ASTRO 2018 Roundup: Fujifilm enters US CT market with FCT Embrace
Fujifilm (TSE:4901) said this week it launched the FCT Embrace 85cm wide bore computed tomography imaging unit, touting it as the world’s first such device to hit the market. The system launch marks the company’s first foray into the CT field, FujiFilm said. The release was announced at the American Society for Radiation Oncology annual meeting ASTRO in San Antonio, Texas. The FCT Embrace system offers 64 and 128 slice configurations, and is intended for use in both oncology and radiology applications, the Tokyo-based company said. The system offers enhanced CT simulation and radiotherapy treatment pl...
Source: Mass Device - October 22, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Imaging Oncology fujifilm Qfix Positioning royalphilips Varian Medical Systems ViewRay Inc. Source Type: news

Vivos raises money to advance products, nix debt
Medical isotope developer Vivos late last month completed a common stock equity...Read more on AuntMinnie.comRelated Reading: Advanced Medical Isotope changes name AMIC reports progress on RadioGel FDA clearance AMIC resubmits Y-90 RadioGel to FDA AMIC nets brachytherapy-related patent AMIC looks for European investors (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 10, 2018 Category: Radiology Source Type: news

IsoRay's GammaTile therapy receives FDA OK
Medical isotope developer IsoRay has received 510(k) clearance from the U.S....Read more on AuntMinnie.comRelated Reading: IsoRay revenues climb in Q4 IsoRay highlights cesium-131 brachytherapy research IsoRay touts prostate cancer treatment data FDA responds to IsoRay's GammaTile 510(k) Court approves IsoRay class-action settlement (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 11, 2018 Category: Radiology Source Type: news

IsoRay inks $8m private placement deal
IsoRay (NYSE:ISR) has inked a private placement deal worth approximately $8.3 million, according to an SEC filing posted this week. Through the deal, Richland, Wash.-based IsoRay is floating 11 million shares of common stock at 75¢ per share with several institutional and accredited investors, according to the filing. The company said it will also offer unregistered warrants to purchase a number of shares equal to 50% of the investors shares at an exercise price of 75¢, exercisable six months after issuance out to 5.5 years, according to an SEC filing. A total of 5.5 million shares will be offered through th...
Source: Mass Device - July 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Wall Street Beat IsoRay Source Type: news

IsoRay wins FDA nod for GammaTile brain tumor treatment
IsoRay (NYSE:ISR) said today it won FDA 510(k) clearance for its GammaTile brachytherapy technology designed for treating recurrent brain tumors. The Richland, Wash.-based company’s GammaTile is a radiation system using Cesium-131 radiation seeds embedded in a collagen ’tile’ which is designed to be placed in surgical margins at the time of surgery. IsoRay said it had previously inked a collaborative development and ten-year supply agreement for the newly cleared GammaTile with GT Medical Technology, which the company said will be available in the US “in the near future.” “We are ve...
Source: Mass Device - July 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Neurological Oncology Regulatory/Compliance IsoRay Source Type: news

Living With Cancer: Prostate cancer brachytherapy
Prostate cancer brachytherapy: Can radiation pass to others?? Prostate brachytherapy is a form of radiation therapy used to treat prostate cancer. The radioactive "seeds" are implanted into the prostate gland, so that radiation is delivered directly to the prostate, minimizing radiation to the surrounding tissue. Depending on the type of prostate cancer brachytherapy you receive, [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 22, 2018 Category: Databases & Libraries Source Type: news

Dr. Gawande tapped to lead Amazon-JPM-Berkshire health play | Personnel Moves – June 21, 2018
The joint healthcare venture between Amazon (NSDQ:AMZN), Berkshire Hathaway and J.P. Morgan Chase said this week it named Brigham and Women’s Hospital surgeon, New Yorker magazine staff writer and bestselling author Dr. Atul Gawande as its CEO, effective July 9. The joint venture said that the newly formed company will be headquartered in Boston, and will operate as an independent entity free from profit-making incentives and constraints. Dr. Gawande also serves as a professor of Harvard Medical School and the Harvard T.H. Chan School of Public Health, and is the founding executive director of health system...
Source: Mass Device - June 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News AirXpanders Amazon Avantis Medical Systems Inc. Berkshire Hathaway Boston Scientific CHF Solutions Inc. Corindus Vascular Robotics Haemonetics Intuitive Surgical IsoRay JP Morgan Chase medicen Medtronic Source Type: news

CDH Beats Varian in Bid for Embattled Sirtex
Money talked and Sirtex Medical listened. The New South Wales, Australia-based medical device company that provides a targeted internal radiation therapy for certain liver cancers, said its board decided that the competing bid from CDH Investments was superior to the earlier bid it received from Varian. In January, Palo Alto, CA-based Varian offered to pay about $1.3 billion (A$28 a share) to acquire Sirtex, and the two companies entered into an agreement, which Sirtex shareholders were expected to approve on May 7. That was until CDH, a major alternative asset management firm based in Beijing, Chi...
Source: MDDI - June 14, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

CFDA drafts guidance on 3D-printed medical devices
The China Food and Drug Administration (CFDA) has released a draft guidance...Read more on AuntMinnie.comRelated Reading: China clears Elekta's Gamma Knife Icon iCAD scores Chinese OK for balloon applicators ViewRay gets Chinese approval for MRIdian system Celsion wins Chinese approval for ThermoDox study China approves Elekta's Flexitron brachytherapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 11, 2018 Category: Radiology Source Type: news

FDA clears Mobius Imaging ’ s Airo Mobile CT imager for pediatric use
Mobius Imaging said yesterday it won FDA 510(k) clearance for its Airo Mobile CT imaging system designed for pediatric applications. The Shirley, Mass.-based company said it previously won FDA 510(k) clearance in 2013 for non-pediatric imaging, and is designed for use in applications supporting brachytherapy, radiation therapy and surgical imaging. The new clearance is an important milestone for the company, Mobius said, expanding the use of the Airo CT system into new segments and applications. “There is an unmet need in being able to provide safe and reliable CT imaging for pediatric patients during various clinica...
Source: Mass Device - April 27, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Imaging Regulatory/Compliance mobiusimaging Source Type: news

EBRT with Brachytherapy Matches Surgery for Prostate Ca (CME/CE)
(MedPage Today) -- Worse survival without boost in high-risk patients (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - April 25, 2018 Category: Primary Care Source Type: news

Low Risk for Ureteral Stricture From Cervical Ca Brachytherapy Low Risk for Ureteral Stricture From Cervical Ca Brachytherapy
Neither intracavitary nor interstitial brachytherapy increases the risk for ureteral stricture in locally advanced cervical cancer, except in the setting of hydronephrosis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 24, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Hydronephrosis Ups Risk of Deadly Complication in Cervical Ca (CME/CE)
(MedPage Today) -- Pronounced increase in risk for severe ureteral stricture post-brachytherapy (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 24, 2018 Category: Hematology Source Type: news

Brachytherapy for cervical cancer does not increase the risk of ureteral stricture
(European Society for Radiotherapy and Oncology (ESTRO)) New research presented at the ESTRO 37 conference from two large international trials, shows that intracavitary and interstitial brachytherapy is safe and does not increase the risk of ureteral stricture in cervical cancer patients. Until now, there have been concerns that brachytherapy might increase the risk of this serious, sometimes life-threatening complication, although the treatment itself is associated with better survival. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 20, 2018 Category: Cancer & Oncology Source Type: news

Selective internal radiation therapy (SIRT) fails to extend survival in the SORAMIC study palliative cohort
(European Association for the Study of the Liver) ILC 2018: The addition of SIRT to sorafenib in patients with advanced hepatocellular carcinoma was associated with no overall survival benefits compared with sorafenib alone, but may offer benefits in some subgroups of patients (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 13, 2018 Category: Cancer & Oncology Source Type: news

Varian Medical releases new Velocity cancer imaging software
Varian Medical (NYSE:VAR) said today it launched an FDA-cleared version of its Velocity cancer imaging software, including a new Rapidsphere module. The newly launched Velocity 4.0’s Rapidsphere module is designed for Y90 selective internal radiation therapy dosimetry analysis and provides improved information on tumor responses and normal-tissue toxicity for patients undergoing SIRT, the Palo Alto, Calif.-based company said. The Velocity 4.0 software includes the company’s Velocity M3i multi-modality motion imaging component, the Velocity Aria sync component and the Velocity tumor & dose tracking comp...
Source: Mass Device - April 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Imaging Oncology Software / IT Varian Medical Systems Source Type: news

High-dose radiotherapy lowers prostate cancer recurrence
Increasing the radiotherapy dose for prostate cancer patients reduced their...Read more on AuntMinnie.comRelated Reading: Societies release guideline for localized prostate cancer Shortened RT works for low-risk prostate cancer patients ASTRO: Prostate cancer has 3 molecular subtypes C4 touts MRI-guided prostate brachytherapy study Experience counts in treating prostate cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 26, 2018 Category: Radiology Source Type: news